Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Performance of Two-stage Cervical Cancer Screening Algorithms Using Primary High-risk Human Papillomavirus Testing in Botswana

NCT04242823 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.

NCT NCT04242823
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04242823 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Performance of Two-stage Cervical Cancer Screening Algorithms Using Primary High-risk Human Papillomavirus Testing in Botswana
Lead sponsor
Beth Israel Deaconess Medical Center
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 22, 2021
Completion date
February 1, 2027
Enrollment
3,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, prevention